MedinCell secures $19Mn grant from Bill & Melinda Gates Foundation
Category: #business  | By Nikita Chaurasia  | Date: 2019-11-30 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

MedinCell secures $19Mn grant from Bill & Melinda Gates Foundation

MedinCell S.A., a French pharmaceutical company, has signed an agreement with the Bill & Melinda Gates Foundation for an additional $19 million that would be offered over the next four years. The arrangement focuses on funding preclinical activities along with a Phase 1 clinical study for mdc-WWM, the injectable six-month bioresorbable contraceptive. 

According to reliable sources, the grant is designed to take care of the project costs via advanced installments. Depending on the developments of the study and on options chosen, a maximum of $11.75 million can be funded over the next year which contains the first tranche of $4.75 million that needs to be paid first following the remaining $7.25 million.

Earlier in 2017, the Gates Foundation had granted a $3.5 million funding to back the formulation research phase. Meanwhile, the French pharma possesses the global marketing rights of the product, including in the U.S., where the contraceptive market has garnered over $5 billion in 2018.

In fact, LARC (Long-acting reversible contraceptives) alone held 28% of this market, valuing over $1.4 billion. The mdc-WWM product can secure an important chunk of this LARC market. Also, it has the potential to further easen the acceptance of this contraception.

Reportedly, MedinCell had prior made headlines when it collaborated with Cornerstone Animal Health to advance a variety of state-of-the-art long-acting injectable veterinary items using the its BEPO® proprietary technology.

Sources cite that Cornerstone would head the funding regulatory development and either commercialize or license the item. The agreement focuses on supporting the financial capability of BEPO® in animal health to advance MedinCell’s profitability as well as to make long-term sustainable profits. Moreover, the JV is designed to reduce the impact on the biotech’s resources and cash.

For the uninitiated, Cornerstone Animal Health is an Animal Health commercialization group based in the United States. It was created by seasoned veterans of the industry with majority of the founders being former executives of iconic firms like Merck Animal Health, Merial or Pfizer Animal Health (Zoetis).
 

Source Credit: https://www.businesswire.com/news/home/20191128005494/en/Medincell-Receives-19-Million-Grant-mdc-WWM-Program

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Samsung kickstarts chip production with 3nm process technology

Samsung kickstarts chip production with 3nm process technology

By Nikita Chaurasia

Samsung Electronics Co Ltd has reportedly declared that it has begun the mass production of chips using advanced 3-nanometre technology. The company is the first in the entire world to do so and is actively looking for new clients to contest with Tai...

Progcap nabs $40Mn in funding round for expansion & product development

Progcap nabs $40Mn in funding round for expansion & product development

By Nikita Chaurasia

Progcap, a pioneer in the field of corporate-driven financing solutions for small and medium-sized businesses (SMBs), has secured $40 million in private equity capital at $600 million valuation. The raised capital forms a part of the Series C exte...

Microsoft solidifies Qatar investment; Unveils new high-tech office

Microsoft solidifies Qatar investment; Unveils new high-tech office

By Nikita Chaurasia

Microsoft, the global tech behemoth, has recently stated that it is expanding its operation in Qatar by unveiling a new Lusail City unit, the firm’s largest and fourth in the country. This new facility forms part of a substantial investment tha...